Ownership history in MILLENNIUM MANAGEMENT LLC · 21 quarters on record
This page tracks every 13F SEC filing in which MILLENNIUM MANAGEMENT LLC reported a position in INNATE PHARMA S A (IPHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 20,308 | +8,647 | +74.2% | 0.00% | $36K | $1.75 |
| 2025 Q2 | REDUCED | 11,661 | -3,665 | -23.9% | 0.00% | $20K | $1.82 |
| 2025 Q1 | ADDED | 15,326 | +4,747 | +44.9% | 0.00% | $27K | $1.78 |
| 2024 Q1 | REDUCED | 10,579 | -1,423 | -11.9% | 0.00% | $30K | $2.88 |
| 2023 Q4 | REDUCED | 12,002 | -34,971 | -74.4% | 0.00% | $34K | $2.80 |
| 2023 Q3 | REDUCED | 46,973 | -2,477 | -5.0% | 0.00% | $119K | $2.53 |
| 2023 Q2 | REDUCED | 49,450 | -12,449 | -20.1% | 0.00% | $155K | $3.08 |
| 2023 Q1 | REDUCED | 61,899 | -9,785 | -13.7% | 0.00% | $176K | $2.85 |
| 2022 Q4 | ADDED | 71,684 | +57,050 | +389.8% | 0.00% | $267K | $3.73 |
| 2022 Q3 | REDUCED | 14,634 | -2,222 | -13.2% | 0.00% | $29K | $2.00 |
As of 2025 Q4 — sorted by position size